JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cotten, M. Dev.
Right arrow Articles by Keller, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cotten, M. Dev.
Right arrow Articles by Keller, J. G.
Journal of Pharmacology And Experimental Therapeutics, Vol. 121, Issue 2, 183-190, 1957
Copyright © 1957 by American Society for Pharmacology and Experimental Therapeutics


A COMPARISON OF THE EFFECTIVENESS OF ADRENERGIC BLOCKING DRUGS IN INHIBITING THE CARDIAC ACTIONS OF SYMPATHOMIMETIC AMINES

Marion Dev. Cotten 1, Neil C. Moran 1, Phyllis E. Stopp 1, and John G. Keller 1

1 Laboratory of Chemical Pharmacology, National Heart Institute, National Institutes of Health, Public Health Service, U. S. Department of Health, Education and Welfare, Bethesda, Maryland

Five adrenergic blocking drugs, each representing a different chemical class, have been examined for their effectiveness in inhibiting the increases in cardiac contractile force produced by levarterenol, epinephrine and isoproterenol in dogs with intact circulatory systems. Phentolamine and Dibenzyline completely blocked the cardiac actions of the amines, whereas large doses of piperoxan and azapetine blocked the effects by 50 to 75 per cent. Hydergine, even in very large doses, produced only 15 to 30 per cent blockade. With each blocking drug, the dose required to inhibit the cardiac responses of the amines was larger than that required to reverse the pressor response toepinephrine. None of the blocking drugs had any demonstrable influence upon the increases in contractile force produced by ouabain.

Submitted on June 15, 1957







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1957 by the American Society for Pharmacology and Experimental Therapeutics.